These data indicate that in PBMCs of people with primary progressive multiple sclerosis, OCR treatment profoundly depletes B cells as well as CD20dim CD4+ and CD8+ T cells and that this depletion contributes to an overall loss of CXCR3+ and CCR5+ T cells especially in the CD8+ memory pool. The gene discussed is CD8A; the disease is primary progressive multiple sclerosis.